Synairgen’s share price rises 540% on morning of news of successful drugs trial
Three professors at the University of Southampton school of medicine have this week made a “major breakthrough” in the treatment of coronavirus patients and become paper millionaires at the same time.
Almost two decades ago professors Ratko Djukanovic, Stephen Holgate and Donna Davis discovered that people with asthma and chronic lung disease lacked a protein called interferon beta, which helps fight off the common cold. They worked out that patients’ defences against viral infection could be boosted if the missing protein were replaced.
Epidemics of infectious diseases behave in different ways but the 1918 influenza pandemic that killed more than 50 million people is regarded as a key example of a pandemic that occurred in multiple waves, with the latter more severe than the first. It has been replicated – albeit more mildly – in subsequent flu pandemics.
Very proud of my husband’s efforts!!
He is the CSO of this company. He and has team have worked their socks off over the last 5 months to make this happen.
And the results are stunning! #COVID19 #Synairgen #SNG #clinicaltrials https://t.co/NThZDV1k0O
